Explore the latest in venous thromboembolism, including the latest in risk prediction and management with newer oral anticoagulants.
This Medical News article discusses recent research that shows increasing their vitamin K intake could help patients who take warfarin to maintain stable anticoagulation.
This noninferiority trial compares the safety and efficacy of a lower (1.8) vs higher (2.5) target international normalized ratio to prevent venous thromboembolism in patients given with warfarin just before or after hip or knee arthroplasty.
This randomized clinical trial conducted in 9 countries compares the use of dabigatran with warfarin in stroke prevention among patients who just experienced cerebral venous thrombosis.
This study uses Medicare billing codes to characterize trends in readmission and mortality rates for Medicare fee-for-service beneficiaries with pulmonary embolism (PE) between 1999 and 2015 to assess changes accompanying recent diagnostic and therapeutic changes in management of the disease.
This diagnostic study evaluates whether a machine learning model, the Pulmonary Embolism Result Forecast Model (PERFORM), can compute a patient-specific risk score for pulmonary embolism as clinical decision support for computed tomography.
A woman in her early 70s presented with altered mental status and decreased power in her left extremities.
This cohort study estimates the risk of and factors associated with recurrent venous thromboembolism in patients undergoing surgery who have a history of venous thromboembolism.
This registry-based cohort study compares adverse event rates up to 3 years after initiation of treatment among patients receiving combination warfarin and aspirin therapy (without a therapeutic indication for aspirin use) vs those receiving warfarin monotherapy.
This report of a case describes a man in his 70s with type 2 diabetes, hypertension, and hyperlipidemia who presented to the emergency department with 4 days of progressive dizziness, shortness of breath, and chest pain on exertion.
This study uses 3 distinct statistical approaches to examine the association between use of inferior vena cava filters and mortality rates in Medicare fee-for-service beneficiaries with pulmonary embolism.
This analysis of data from the Emerging Risk Factors Collaboration and the UK Biobank estimates the associations of major cardiovascular risk factors with venous thromboembolism.
This Viewpoint analyzes data on the thrombotic risk associated with cyclin-dependent kinase inhibitors and notes the need for additional research on the thrombotic risk of these drugs, the influence of combined drug therapy on thrombotic risk, and patient selection.
This cohort study examines whether aspirin as a single agent is inferior to other anticoagulation agents for reducing the risk of venous thromboembolism or major bleeding events after unilateral primary total knee arthroplasty.
This Clinical Evidence Synopsis summarizes a Cochrane review of randomized trials comparing the effects of treatment of lower extremity superficial thrombophlebitis on venous thromboembolism and major bleeding.
This population-based analysis uses data from a US nationwide insurance claims database to assess the risk of venous thromboembolism associated with keratinocyte carcinoma within 1 year following the date of diagnosis and compares rates of venous thromboembolism among patients with or without cancer.
This pre-post intervention comparison study evaluates a real-time patient-centered education bundle intervention aimed to reduce nonadministration of venous thromboembolism prophylaxis among hospitalized patients in surgical and medical units.
This cohort study compares the risk for venous thromboembolism among women who use extended cyclic and continuous combined oral contraceptives (COCs) with that among women who use traditional cyclic COCs, while holding the progestogen type constant.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: